OBJECTIVES: To evaluate the use of influenza vaccine in nursing homes and its effectiveness in reducing the likelihood of influenza-like illness. DESIGN: A retrospective case-control study with active identification of influenza infection. SETTING: All nursing homes in a seven-county study area in southern lower Michigan were eligible for participation. Analyses were based on data collected from 23 homes with documented influenza transmission. PARTICIPANTS: Persons aged 65 years or older who were residents of the nursing homes under study during the influenza type A(H3N2) outbreak in [1989][1990]. MEASUREMENTS: Residents were identified as cases or controls based on occurrence of febrile respiratory illness meeting a case definition. Demographic and underlying illness information were gathered as were data on the use of influenza vaccine, antibiotics, and antivirals. Characteristics of the nursing homes were also recorded. Logistic regression analyses were carried out to determine vaccine effectiveness. MAIN RESULTS: Determinants of vaccine use were different from those observed in a parallel community-based study. In a multivariate model that considered the effects of resident and nursing home characteristics, vaccinated residents were significantly less likely than those who were not vaccinated to have an influenza-like illness (OR = .58 (95% CI, .43-.78), P < .001, imputed vaccine effectiveness estimate of 42%).
I than 50 years. Repeated controlled evaluations of their efficacy in young adults, typically military recruits, demonstrated prevention of laboratory-confirmed clinical disease in the range of 70 to 90%.' Until recently, many have questioned the value of influenza vaccination in an older, more frail population because of the occurrence of nursing home outbreaks even in situations where the circulating virus was similar to that in the ~a c c i n e .~-~ A series of observational studies have confirmed that, in older persons living in the community, the vaccine has been significantly protective against outcomes such as hospitalization and, in some cases, death?-* Largely as a result of these studies, influenza vaccination became a Medicare part B-covered benefit in 1993. 9 The situation in nursing homes may be the most extreme test for the current vaccine since, in addition to the increased possibility for spread of infection in these closed environments, many residents are older than 85 years of age and have multiple underlying conditions. lo Most influenza-associated deaths occur among older people, and residents of nursing homes are at especially high risk for severe influenza-related complications. Since the emergence of influenza type A(H3N2) in 1968, seasons dominated by this influenza virus subtype have been associated with the highest mortality compared with seasons dominated by influenza type A(HlN1) or type B viruses. The outbreak during the 1989-1990 influenza season was more severe than that of the average A(H3N2) season, with major pneumonia and influenza mortality among older people nationally and increased morbidity in younger individuals." In an assessment of the impact of influenza epidemics on mortality in the United States from 1972 through 1992, using a severity index ranging from 1 (mildest) to 10 (most severe), the [1989] [1990] season was in severity category 6, one categor below the type A(H3N2) pandemic of [1968] [1969] ." Influenza A(H3N2) viruses isolated nationally were antigenically similar to A/Shanghai/l1/87, the A(H3N2) component of the 1989-1990 influenza vaccine. The current report describes an evaluation that estimated the effectiveness of the vaccine in preventing influenza-like illness in residents of nursing homes experiencing outbreaks of the type A(H3N2) virus using case-control methodology.
METHODS

Survcillancc
The study area consisted of seven counties in southcentral and southwestern lower Michigan. A community- based surveillance system was established within this area from November through April to determine the timing and intensity of influenza virus activity and influenza-like illness.I3 All 83 nursing homes in the seven-county study area were eligible and encouraged to participate in surveillance by reporting weekly on the number of new cases of influenzalike illness occurring among residents. Influenza-like illness (ILI) was defined as an oral temperature (or rectal or axillary equivalent) of at least 37.8"C and one or more of the following signs or symptoms: cough, sore throat, or c o r y~a . '~ Nursing homes were also asked to submit pharyngeal swab specimens for influenza isolation from residents with influenza-like illness; however, influenza virus isolation was not required to meet the case definition. After the period of influenza surveillance ended, the weekly incidence of influenza-like illness activity within each participating nursing home was evaluated. Homes that experienced outbreaks (10% or more of the resident population developed ILI within a 7-day period during periods of laboratory-confirmed community influenza activity) and homes with definitive influenza introduction, based on influenza virus isolation from pharyngeal swab specimens, were targeted for enrollment in the vaccine effectiveness study. All homes recruited for the effectiveness study were required to have kept patient-specific logs throughout the surveillance period on those residents who met the case definition for ILL
Study Population
The eligible study population was comprised of all persons aged 65 years and older who were residents of participating nursing homes, as determined from census lists, at the beginning of the surveillance period, November 1,1989. All homes conducted influenza vaccination programs from late September through early November 1989, and residents' vaccination statuses resulting from these programs were considered here. Cases were those residents who developed influenza-like illness during the period of laboratoryconfirmed community influenza activity. Controls were drawn from the same study population and were required to have not developed ILI during the study period and to reside in the same facility as the case. Up to three controls were identified and group matched by 5-year age category to each identified case. Preference was given to selecting controls who resided in the same geographic area of the facility (wing or floor) as the case. Controls who died before the end of the surveillance period and controls who received amantadine were excluded, and, thus, selected controls had the opportunity to become cases throughout the surveillance period.
Data Collection
Data on cases and controls were collected retrospectively by nursing home staff using survey forms developed by study personnel. Data sources within nursing homes were individual resident medical records, nurses' notes, pharmacy records, infection control logs, and the resident-specific case identification logs generated throughout the surveillance period. For each case or control, information about the following variables was requested: resident's gender, date of birth, admission date, date of onset of illness for cases, 1989-1990 influenza vaccination status, pneumococcal vaccination status, the existence of certain chronic or comorbid conditions (heart disease, lung/pulmonary disease, diabetes, renal disease, cancer, dementia, Parkinson's disease, hypothyroidism, and anemia), assessment of competency to give consent for their own medical treatment, amantadine use, antibiotic use, discharge status and date, and date of death, if applicable.
Data Analysis
Individuals were classified as vaccinated if their records indicated influenza vaccination for the 1989-1990 season during fall vaccination programs. Those whose records indicated not being vaccinated and those with unknown vaccination status were coded as unvaccinated. Age was represented by six 5-year categories from 65 to 90 or older. Pneumococcal vaccination status was classified as vaccinated, unvaccinated, or unknown. Specified chronic or comorbid conditions, as described previously, and competency to give consent for their own medical treatment were coded as present if reported as such, absent otherwise. Individuals who were discharged, transferred and/or who died were identified. Cases who died within 1 month of influenza-like illness onset were considered to have died as a result of influenza-related complications. Antibiotic and amantadine use were coded as present if reported as such, absent otherwise.
In order to consider characteristics of individual nursing homes that might affect both the introduction of influenza into the home and transmission of influenza within the home, values for size of home (number of beds) and overall influenza vaccination level (percent vaccinated) for each participating nursing home were obtained from the 1989-1990 Nursing Home Survey" and included in this analysis. Number of beds was expressed as a dichotomous variable representing small (5100 beds) and large (>lo0 beds) homes, based on a frequency distribution of the number of beds. Percent vaccinated was expressed as a dichotomous variable representing those homes above and below the overall median (and mean) of 75% vaccinated.
The statistical significance of differences in characteristics between cases and controls and between vaccinated and unvaccinated individuals were evaluated using cross tabulations and chi-square statistics." Logistic regression analyses17 were used to estimate the effectiveness of influenza vaccination in reducing the likelihood of influenza-like illness while adjusting for study population and nursing home characteristics that influenced this relationship. Two techniques were used to control for the effect of individual nursing home characteristics on the evaluation of influenza vaccine effectiveness. The first technique used conditional logistic regression to evaluate vaccine effectiveness conditional on nursing home. In this analysis, cases were compared only with controls within the same nursing home, and an overall measure of vaccine effectiveness was estimated. The second technique was developed for the purpose of considering the impact of theoretically important characteristics of nursing homes while estimating overall influenza vaccine effectiveness. Information on number of beds and overall percentage of influenza-vaccinated residents, as described previously, were selected to represent important features of nursing homes. Information on overall percentage of residents vaccinated was not available for five of the nursing homes represented in the case-control study.
Estimates of the effectiveness of vaccine in preventing a rare condition in case-control studies can be derived from the logistic regression models as being equivalent to 1 minus the odds ratio (1-OR). Influenza-like illness in the present study was a relatively frequent outcome, suggesting that this deri- vation may not be directly appropriate. In order to permit comparison with the effectiveness measures derived in other studies, calculations that will be referred to as "imputed vaccine effectiveness estimates" are included here in addition to measures of reduced odds or likelihood.
RESULTS
Influenza Virus Activity Influenza A(H3N2) was the only type of influenza virus detected in the study area during the 1989-1990 season, and the strain was antigenically similar to the strain that circulated nationally and included as the A(H3N2) component of the 1989-1990 vaccine. Influenza was first isolated from a conimunity-acquired specimen in late November 1989; virus isolation continued through March 1990. 13 The majority of the late season isolates were from nursing homes. Sixty-five (78%) study area homes participated in influenza-like illness surveillance by submitting weekly data on illness incidence. Thirty-one (37%) homes provided pharyngeal swab specimens for influenza virus isolation.
Population Characteristics
Because the underlying assumption of these analyses was that all included cases and controls were exposed to circulating influenza virus, only homes with definitive introduction of influenza were included. Twenty-three nursing homes had evidence of influenza introduction based on outbreak activity (17 homes) or isolation of influenza virus from pharyngeal swab specimens (21 homes).Is This restriction resulted in a study population of 1198 residents: 361 cases (30%) and 837 controls (70%). Table 1 shows the distribution of study population characteristics by case-control status. Overall, 71% of the study population were reported to have received the influenza vaccine for the 1989-1990 season; 61% of cases and 75% of controls received vaccine (OR = 5 2 (95% CI, .40-.67) , imputed vaccine effectiveness estimate of 48%)). Women, who made up 80% of the total study population but only 76% of the cases, were significantly less likely than men to develop ILI (OR = .74 (95% CI, 35-.99) ). Cases and controls did not differ significantly by age categories as determined in the study design. Pneumococcal vaccination confirmed from nursing home records was identified in less than 18% of the study population and did not differ by case or control status; pneumococcal vaccination status was unknown in 59% of the study population. Significantly more cases were reported to have lung disease (OR = 1.62 (95% CI, 1.05-2.50)) and renal disease (OR = 2.23 (95% CI, 1.14-4.41)), whereas significantly more controls were assessed as being competent to give consent for their own medical treatment (OR = .61 (95% CI, .45-.82)). Table 2 shows the distribution of study population characteristics by influenza vaccination status. Men were slightly, but not significantly, more likely to be vaccinated than women. There were no significant differences in vaccination status by age category. Nursing home residents who were reported to have dementia (OR = 1.90 (95% CI, 1.47-2.45)) or Parkinson's disease (OR = 2.31 (95% CI, 1.22-4.37)) were significantly more likely to be vaccinated than those without these conditions. Nursing home residents with renal disease (OR = .48 (95% CI, .25-.96) ), lung disease (OR = 5 9 , (95% CI, .38-.91)), heart disease (OR = .75 (95% CI, 39-.97)), and those residents competent to give consent for their own treatment (OR = .75 (95% CI, 57-.99)) were significantly less likely to have received influenza vaccine. Residents whose medical records indicated that they had received pneumococcal vaccine were significantly more likely to have also received influenza vaccine (OR = 2.48 (95% CI, 1.63-3.77) ).
Influenza Vaccine Effectiveness
Tables 3 and 4 show the results of two different logistic regression analyses used to estimate the effectiveness of influenza vaccination in reducing the likelihood of influenza-like illness among residents while adjusting for the effects of nursing home and resident characteristics. Table 3 presents the results of the conditional logistic regression. In this model, the odds ratio of 5 8 indicates a significant reduction for vaccinated individuals in the likelihood of having an influenza-like illness during the surveillance period (95% CI, .43-.78, P < .001, imputed vaccine effectiveness estimate of 42%). Resident competency, but not lung or renal disease, remained significantly associated with the outcome in this model. This analysis was adjusted for sex and age category and was conditional on individual nursing home. Table 4 presents the results of the logistic regression analysis that considers the effect of potentially important nursing home characteristics on the likelihood of influenzalike illness among residents. The odds ratio of 5 8 associated with influenza vaccination again corresponds to a reduction in the odds of developing ILI among the vaccinated (95% CI, .42-.79, P < .001, imputed vaccine effectiveness estimate of 42%). In this model, lung disease and resident competency were associated significantly with the outcome. Although nursing home size did not have an impact on the likelihood of influenza-like illness among residents, overall vaccination levels did. This effect, although not statistically significant, suggested reduction in the likelihood of illness among residents of homes with higher overall vaccination levels. This analysis included only cases and controls from the nursing homes with information on overall percent vaccinated. When the original conditional logistic regression model was applied to this subset population of 18 nursing homes, the odds ratio associated with influenza vaccination was estimated at .64 (P = .007, imputed vaccine effectiveness estimate of 36%).
Vaccine effectiveness may be lower in older people because of a number of factors, and extreme old age may be a surrogate for these factors. We evaluated vaccine effectiveness in two subsets of nursing home residents based on age group. The study population was divided into two approximately equal subsets of residents: those 65 to 84 years old and those older than 84 years. The proportion of individuals who had received influenza vaccine was not significantly different between those aged 65 to 84 years and those more than 84 years old (69% vs 73%, respectively, P = .15). Table 5 shows the results of the conditional logistic regression on the younger subset. Influenza vaccination was associated with a significant reduction in the odds of ILI in the younger age group (OR = .56 (95% CI, .37-.84), P = .005, imputed vaccine effectiveness estimate of 44%). Table 6 shows identical analyses on the subset older than 84 years and although the analysis suggests reduced odds of ILI among the vaccinated subjects, the estimate was not statistically significant (OR = .65 (95% CI, .42-1.01), P = .053, imputed vaccine effectiveness estimate of 35%).
When cases of all ages were examined, it was found that 75% were treated with antibiotics during their illness, although only 36 cases (10%) were identified as having pneumonia in association with their influenza-like illness. Amantadine was used therapeutically in 70 cases in eight nursing homes; 90% of the treated cases resided in three homes. Thirty-three residents (9%) died within 1 month of influenzalike illness onset and were considered to have died as a result of influenza-related complications; overall, 45 cases (12%) died during the surveillance period. There were too few individuals who had influenza-related pneumonia or who died to evaluate the effectiveness of influenza vaccination in reducing the likelihood of these events.
DISCUSSION
Although inactivated influenza vaccines have been known for many years to be effective in preventing illness in young adults, the value of the vaccine in older individuals has continued to be q~e s t i o n e d .~-~ For older persons living in the community, studies reported during the period 1992-1995 using different methods in different popula- tions demonstrated that the vaccines were between 31 and 57% effective in preventing hospitalization for illnesses diagnosed as pneumonia or influenza during the influenza season; in studies using a case control design, the range was 31 to 45%. [5] [6] [7] [8] In all studies, the likelihood of these diagnoses actually representing illnesses caused by influenza was increased by timing the data collection to coincide with laboratory-defined influenza virus circulation. The cases were not identified by laboratory confirmation but by their having diagnoses considered compatible with influenza or an influenza-related complication. The consistency among these different studies is remarkable because the seasons were sometimes dominated by type B virus, and the exact clinical diagnostic categories considered in the individual studies varied. In all of these studies, there were unknown percentages of cases that were included but did not truly represent influenza-related illness, and this would lower estimates of vaccine effectiveness. In the current study, the primary outcome was also an epidemiologic one: an influenza-like illness meeting a broad case definition during a period of confirmed community influenza activity. To increase the likelihood that influenza was the cause of illness in persons who met the case definition for ILI in this study, nursing homes were required to have evidence of introduction of the influenza virus to be included. However, because illnesses were not confirmed with influenza virus isolation, it is clear that our epidemiologic definition is not a clinical one and that some cases classified as ILI might not have actually been influenza-related illnesses." A large number of homes contributed data and thus can be considered to be broadly representative of all those in the region. Odds ratios generated from logistic regression analyses were used to estimate the reduction in the likelihood of ILI among vaccinated residents. Generally, estimates of vaccine effectiveness in preventing a rare condition in case control studies can be derived from the logistic regression models as being equivalent to 1 minus the odds ratios (1-OR). Inasmuch as ILI was not a rare outcome in the course of influenza outbreaks in the nursing homes described here, this derivation may not be directly appropriate. However, this was done to allow comparison with the results of other studies, especially since there is a body of opinion that views this derivation to approximate vaccine effectiveness
